AmyriAD Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Angel
- Investors
-
3
AmyriAD General Information
Description
Operator of a clinical-stage biopharmaceutical company intended to develop therapies for Alzheimer's disease. The company engages in developing a drug that is an orally administered small molecule treatment that enhances neurotransmission in the brain and improves both cognition and independent global function, enabling medical practitioners to use neurotransmission and improve both cognition and independent global function.
Contact Information
Website
www.amyriadtherapeutics.comCorporate Office
- 21370 South West Langer Farms Parkway
- Suite 142-114
- Sherwood, OR 97140
- United States
Corporate Office
- 21370 South West Langer Farms Parkway
- Suite 142-114
- Sherwood, OR 97140
- United States
AmyriAD Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Angel (individual) | 01-Jan-2024 | Completed | Clinical Trials - Phase 3 | |||
| 3. Early Stage VC | 10-Jun-2022 | Completed | Clinical Trials - Phase 3 | |||
| 2. Early Stage VC (Series A) | 27-Nov-2020 | Completed | Clinical Trials - Phase 3 | |||
| 1. Seed Round | 20-Dec-2019 | Completed | Clinical Trials - Phase 3 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AmyriAD Comparisons
Industry
Financing
Details
AmyriAD Competitors (6)
One of AmyriAD’s 6 competitors is Alzheon, a Venture Capital-Backed company based in Framingham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Neumora | Formerly VC-backed | Watertown, MA | ||||
| Prothena | Corporation | Dublin, Ireland | ||||
| Acumen Pharmaceuticals | Formerly VC-backed | Newton, MA | ||||
| Altos Labs | Private Equity-Backed | Redwood City, CA |
AmyriAD Signals
AmyriAD Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Frühstarter Ventures | Angel Group | Minority | ||
| Korify Capital | Venture Capital | Minority | ||
| Stern Stewart Ventures | Corporate Venture Capital | Minority |
AmyriAD Acquisitions (1)
AmyriAD’s most recent deal was a Merger/Acquisition with Recognify Life Sciences. The deal was made on 07-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Recognify Life Sciences | 07-Oct-2026 | Merger/Acquisition | Drug Discovery |
AmyriAD Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Recognify Life Sciences | Berlin, Germany | 2018 |
AmyriAD FAQs
-
When was AmyriAD founded?
AmyriAD was founded in 2019.
-
Where is AmyriAD headquartered?
AmyriAD is headquartered in Sherwood, OR.
-
What is the size of AmyriAD?
AmyriAD has 6 total employees.
-
What industry is AmyriAD in?
AmyriAD’s primary industry is Drug Discovery.
-
Is AmyriAD a private or public company?
AmyriAD is a Private company.
-
What is AmyriAD’s current revenue?
The current revenue for AmyriAD is .
-
How much funding has AmyriAD raised over time?
AmyriAD has raised $404K.
-
Who are AmyriAD’s investors?
Frühstarter Ventures, Korify Capital, and Stern Stewart Ventures have invested in AmyriAD.
-
Who are AmyriAD’s competitors?
Alzheon, Neumora, Prothena, Acumen Pharmaceuticals, and Altos Labs are some of the 6 competitors of AmyriAD.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process